Clausen P P, Lindskov J, Gad I, Kreutzfeldt M, Orholm M, Reinicke V, Larsen H R, Strøm P
Liver. 1984 Dec;4(6):353-9. doi: 10.1111/j.1600-0676.1984.tb00951.x.
In order to determine the diagnostic value of alpha 1-antitrypsin (AAT) globules as a morphological marker of AAT-deficiency of the Pi-Z type, liver needle biopsies from a prospective series of 600 patients were stained with PAS after pretreatment with diastase and by indirect immunoperoxidase staining for AAT deposits. Serum AAT phenotypes of the patients were determined by means of isoelectric focusing. Thirty-two biopsies were from patients with the Pi-Z allele (31 MZ, 1 Z), and 568 biopsies from patients without the Pi-Z allele. AAT globules larger than 3 micron were found in 16 biopsies of which 15 were from patients with the Pi-Z allele (diagnostic specificity 0.94), whereas 20 of 26 biopsies with AAT globules larger than 1 micron were from Pi-Z patients (diagnostic specificity 0.77). Only 47% of the biopsies from patients with the Pi-Z allele contained AAT globules larger than 3 micron. Thus, although AAT globules larger than 3 micron are highly specific as a morphological marker of the Pi-Z allele, their rather infrequent occurrence in carriers of the Pi-Z allele indicates that all investigations concerning the correlation between AAT deficiency of the Pi-Z type and liver disease should be based on phenotyping of sera from all the patients.
为了确定α1-抗胰蛋白酶(AAT)小球作为Pi-Z型AAT缺乏症形态学标志物的诊断价值,对600例前瞻性系列患者的肝穿刺活检组织在经淀粉酶预处理后进行PAS染色,并通过间接免疫过氧化物酶染色检测AAT沉积。采用等电聚焦法测定患者的血清AAT表型。32例活检组织来自携带Pi-Z等位基因的患者(31例MZ型,1例Z型),568例活检组织来自不携带Pi-Z等位基因的患者。在16例活检组织中发现了直径大于3微米的AAT小球,其中15例来自携带Pi-Z等位基因的患者(诊断特异性为0.94),而在26例直径大于1微米的AAT小球的活检组织中,有20例来自Pi-Z患者(诊断特异性为0.77)。携带Pi-Z等位基因患者的活检组织中只有47%含有直径大于3微米的AAT小球。因此,尽管直径大于3微米的AAT小球作为Pi-Z等位基因的形态学标志物具有高度特异性,但它们在Pi-Z等位基因携带者中出现的频率较低,这表明所有关于Pi-Z型AAT缺乏症与肝脏疾病相关性的研究都应基于对所有患者血清进行表型分析。